This company has been marked as potentially delisted and may not be actively trading. resTORbio (TORC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock TORC vs. BHST, PROC, SAVA, CRBP, VIRI, IOBT, IRWD, PLRX, ZNTL, and ADAGShould you be buying resTORbio stock or one of its competitors? The main competitors of resTORbio include BioHarvest Sciences (BHST), Procaps Group (PROC), Cassava Sciences (SAVA), Corbus Pharmaceuticals (CRBP), Virios Therapeutics (VIRI), IO Biotech (IOBT), Ironwood Pharmaceuticals (IRWD), Pliant Therapeutics (PLRX), Zentalis Pharmaceuticals (ZNTL), and Adagene (ADAG). These companies are all part of the "medical" sector. resTORbio vs. Its Competitors BioHarvest Sciences Procaps Group Cassava Sciences Corbus Pharmaceuticals Virios Therapeutics IO Biotech Ironwood Pharmaceuticals Pliant Therapeutics Zentalis Pharmaceuticals Adagene BioHarvest Sciences (NASDAQ:BHST) and resTORbio (NASDAQ:TORC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability and media sentiment. Do insiders and institutionals have more ownership in BHST or TORC? 46.2% of resTORbio shares are held by institutional investors. 11.8% of resTORbio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is BHST or TORC more profitable? resTORbio has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -76.65%. BioHarvest Sciences' return on equity of 0.00% beat resTORbio's return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-76.65% N/A -85.16% resTORbio N/A -78.12%-71.63% Which has more volatility and risk, BHST or TORC? BioHarvest Sciences has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Comparatively, resTORbio has a beta of 2.43, suggesting that its share price is 143% more volatile than the S&P 500. Does the MarketBeat Community favor BHST or TORC? resTORbio received 137 more outperform votes than BioHarvest Sciences when rated by MarketBeat users. However, 100.00% of users gave BioHarvest Sciences an outperform vote while only 67.14% of users gave resTORbio an outperform vote. CompanyUnderperformOutperformBioHarvest SciencesOutperform Votes4100.00% Underperform VotesNo VotesresTORbioOutperform Votes14167.14% Underperform Votes6932.86% Do analysts recommend BHST or TORC? BioHarvest Sciences presently has a consensus price target of $13.67, suggesting a potential upside of 89.81%. Given BioHarvest Sciences' stronger consensus rating and higher probable upside, analysts plainly believe BioHarvest Sciences is more favorable than resTORbio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00resTORbio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings & valuation, BHST or TORC? BioHarvest Sciences has higher revenue and earnings than resTORbio. BioHarvest Sciences is trading at a lower price-to-earnings ratio than resTORbio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$27.70M4.27-$12.56M-$0.50-14.40resTORbioN/AN/A-$82.74M-$2.41-0.31 Does the media favor BHST or TORC? In the previous week, BioHarvest Sciences had 2 more articles in the media than resTORbio. MarketBeat recorded 2 mentions for BioHarvest Sciences and 0 mentions for resTORbio. BioHarvest Sciences' average media sentiment score of 1.51 beat resTORbio's score of 0.00 indicating that BioHarvest Sciences is being referred to more favorably in the media. Company Overall Sentiment BioHarvest Sciences Very Positive resTORbio Neutral SummaryBioHarvest Sciences beats resTORbio on 10 of the 17 factors compared between the two stocks. Get resTORbio News Delivered to You Automatically Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TORC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TORC vs. The Competition Export to ExcelMetricresTORbioPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.35M$6.87B$5.57B$8.50BDividend YieldN/A2.53%5.28%4.16%P/E Ratio-0.418.4326.6319.64Price / SalesN/A262.52407.99152.17Price / CashN/A65.8538.2534.64Price / Book0.336.536.964.60Net Income-$82.74M$143.25M$3.23B$248.06M resTORbio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TORCresTORbioN/A$0.75-3.8%N/A-44.3%$27.35MN/A-0.41N/AGap DownBHSTBioHarvest SciencesN/A$6.60-2.2%$13.67+107.1%N/A$108.41M$27.70M-5.28N/APROCProcaps GroupN/A$0.95-40.3%N/A-63.0%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeSAVACassava Sciences4.2646 of 5 stars$2.16+1.4%$54.50+2,423.1%-89.7%$104.35MN/A-1.5730Positive NewsCRBPCorbus Pharmaceuticals3.9736 of 5 stars$8.30+13.1%$50.88+513.0%-83.3%$101.57MN/A-1.7740Positive NewsVIRIVirios Therapeutics0.4403 of 5 stars$5.27+1.7%$3.00-43.1%+2,132.8%$101.49MN/A-19.525News CoverageIOBTIO Biotech3.9486 of 5 stars$1.51-6.8%$9.33+518.1%+5.5%$99.48MN/A-1.1030News CoveragePositive NewsAnalyst UpgradeShort Interest ↓IRWDIronwood Pharmaceuticals4.6505 of 5 stars$0.61-1.9%$4.78+684.3%-89.6%$98.69M$317.68M-20.33220Positive NewsGap DownPLRXPliant Therapeutics4.3021 of 5 stars$1.60+11.1%$13.31+732.0%-88.5%$98.22M$1.58M-0.4890Positive NewsAnalyst RevisionGap DownZNTLZentalis Pharmaceuticals2.3139 of 5 stars$1.36+6.3%$8.24+506.2%-85.9%$97.86M$26.87M-0.55160Positive NewsGap DownADAGAdagene2.6911 of 5 stars$2.07-1.0%$8.00+286.5%-31.1%$97.52M$103.20K0.00260 Related Companies and Tools Related Companies BioHarvest Sciences Alternatives Procaps Group Alternatives Cassava Sciences Alternatives Corbus Pharmaceuticals Alternatives Virios Therapeutics Alternatives IO Biotech Alternatives Ironwood Pharmaceuticals Alternatives Pliant Therapeutics Alternatives Zentalis Pharmaceuticals Alternatives Adagene Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TORC) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding resTORbio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share resTORbio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
